| Shareholder | |||||
|---|---|---|---|---|---|
Catalyst4, Inc | 54.57% | 25.31M | 11.22% | +5.61M | |
T. Rowe Price Group, Inc. | 9.07% | 4.20M | 1.88% | +954.40K | |
Forbion Capital Partners B.V. | 6.96% | 3.23M | 0.18% | +0 | |
Novo Holdings A/S | 4.50% | 2.09M | 3.61% | -1.60M | |
Chen's Group International Limited | 3.51% | 1.63M | -- | +1.63M | |
Pivotal BioVenture Partners LLC | 2.77% | 1.28M | 0.72% | -299.65K | |
The Goldman Sachs Group, Inc. | 2.33% | 1.08M | 0.17% | -50.82K | |
BlackRock, Inc. | 2.21% | 1.03M | 0.75% | -314.60K | |
5AM Venture Management, LLC | 2.05% | 950.01K | 0.05% | +0 | |
Sanofi | 1.97% | 912.04K | 0.05% | +0 | |
Vanguard Capital Management, LLC | 1.96% | 907.29K | 0.07% | +56.23K | |
Goldman Sachs Asset Management, L.P. | 1.87% | 865.74K | 0.04% | +4.26K | |
State Street Investment Management | 1.84% | 852.15K | 1.09% | +513.03K | |
FMR LLC | 1.78% | 823.56K | 1.32% | +619.06K | |
CHI Advisors LLC | 1.57% | 729.93K | 0.65% | -276.00K | |
Paradigm Biocapital Advisors LP | 1.48% | 685.85K | -- | +685.85K | |
Velan Capital Partners LP | 1.06% | 492.89K | 0.03% | +0 | |
Artal Group S.A. | 0.97% | 450.00K | 0.03% | +0 | |
Capital Research and Management Company | 0.90% | 415.73K | -- | +415.73K | |
Geode Capital Management, LLC | 0.87% | 402.05K | 0.20% | -79.15K |
